Moneycontrol
Jan 16, 2015 03:42 PM IST | Source: CNBC-TV18

Opto Circuits sees rev growth from coronary stent approval

V Bhaskar of Opto Circuits Group said the company was not looking for any FDI as of now.

V Bhaskar, Director of Opto Circuits Group in an interview to CNBC-TV18 spoke about the company receiving European approval for coronary stent system.

Opto Circuits (India) Ltd had informed BSE that Eurocor GmbH a group Company of Opto Circuits (India) Limited has received CE Mark (Communite European) approval for E-Magic Plus™ Sirolimus Eluting Coronary Stent System.

With this approval the company will be able to enter every other country except US and Japan and except improvement in revenues from this in the coming three four quarters.

Answering a query if the company saw government's decision to allow 100% foreign direct investment (FDI) in medical devices a lucrative opportunity, he said the company per se was not looking for FDI as of now.

For the entire interview watch video

Sections
Follow us on
Available On